STRESS CARDIOMYOPATHY IN COVID-19 DISEASE
Keywords:
Takotsubo syndrome, cardiomyopathy, COVID-19Abstract
Takotsubo syndrome (TTS), also known as stress cardiomyopathy, can occur in COVID-19 pneumonia patients at various stages of the illness and with varying degrees of left ventricular failure. We outline three TTS cases involving COVID-19-positive individuals with various clinical outcomes. One of them passed away, and in the other two, coronary angiography confirmed the diagnosis but was delayed due to the potential for virus spread until after the pneumonia had cleared up.Learning points It is underlined that COVID-19 and cardiac involvement are related. Because Takotsubo syndrome is thought to be brought on by extreme stress, its prevalence has increased throughout this epidemic.
References
Reeder GS, Prasad A. Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy. [accessed 14 May 2020]. Retrieved from https://www.uptodate.com.
Rockwood K, Song X, Macnight C, Bergam H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–495. [PubMed] [Google Scholar]
Radhakrishnan R. Stress cardiomyopathy: aetiology and management. Postgrad Med J. 2007;83(982):543–546. [PMC free article] [PubMed] [Google Scholar]
Meyer P, Degrauwe S, Van Delden C, Ghadri J, Templin C. Typical Takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. Apr 14; doi: 10.1093/eurheartj/ehaa306. pii: ehaa306. [Epub ahead of print] [PMC free article] [PubMed] [CrossRef] [Google Scholar]
